David Schena

Title: David Schena: Innovator in Biochemical Patents

Introduction

David Schena is a notable inventor based in Brighton, MA (US). He has made significant contributions to the field of biochemistry, particularly through his innovative patents. With a total of 2 patents, Schena's work focuses on novel compounds that have potential applications in the production of diacyl phosphatidic acids.

Latest Patents

Schena's latest patents include the development of Mono-N,N-dimethyl-4-aminopyridinium sn-glycerol-3-phosphate derivatives. This invention provides a novel salt of sn-glycerol-3-phosphate comprising mono-N,N-dimethyl-4-aminopyridine. The methods for making and using this compound are aimed at enhancing the production of diacyl phosphatidic acids. His second patent, titled Mono-N,N-dimethyl-4-aminopyridinium sn-glycerol-3-phosphate, shares similar features and applications, further emphasizing his focus on this innovative biochemical compound.

Career Highlights

David Schena is currently associated with Genzyme Corporation, a leading biotechnology company. His work at Genzyme has allowed him to explore and develop groundbreaking biochemical innovations. Schena's expertise in the field has positioned him as a valuable asset to the company and the broader scientific community.

Collaborations

One of Schena's notable collaborators is Jeffrey Davis. Their partnership has likely contributed to the advancement of their research and the successful development of their patents.

Conclusion

David Schena's contributions to biochemistry through his patents demonstrate his innovative spirit and commitment to advancing scientific knowledge. His work continues to have a significant impact on the field, paving the way for future developments in biochemical applications.